Raiffeisen Bank International AG .../ AT0000A3CLJ8 /
| 2/28/2025 12:00:00 AM | Chg.-0.05 | Bid- | Ask- | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 6.17EUR | -0.80% | - Bid Size: - |
- Ask Size: - |
FACC AG INH.AKT. | - EUR | 9/24/2025 | Call |
GlobeNewswire
2/27
Ideal Protein Launches Whitepaper Unveiling Synergistic Approach to Enhance GLP-1 Medication Outcome...
GlobeNewswire
2/25
Kiniksa Pharmaceuticals Announces Development of KPL-387 in Recurrent Pericarditis and Updates Corpo...
GlobeNewswire
2/21
Marius Pharmaceuticals Unveils New Corporate Website and Announces Longevity & Endocrinology Advisor...
GlobeNewswire
2/18
Published Data in The Lancet Diabetes & Endocrinology Highlights Unique Efficacy Benefits of Sotagli...
GlobeNewswire
2/14
Volta Medical Artificial Intelligence-guided Cardiac Ablation Procedure Improves Treatment of Atrial...
GlobeNewswire
1/31
New Truveta study highlights patterns of discontinuation and reinitiation of GLP-1 RA medications
GlobeNewswire
8/26/2024
Milestone® Pharmaceuticals to Present Data on Etripamil at the ESC Congress 2024
GlobeNewswire
8/14/2024
19th Annual Cardiometabolic Health Congress: Honoring the Life and Legacy of CMHC Co-Chair Dr. Georg...
GlobeNewswire
8/13/2024
Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Expansion of the Phase 2b MOVE-IT Study of ...
GlobeNewswire
8/12/2024
Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
8/8/2024
Milestone Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Regulatory and ...
GlobeNewswire
7/31/2024
BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation
GlobeNewswire
7/28/2024
Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alz...
GlobeNewswire
7/18/2024
HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in ...
GlobeNewswire
7/17/2024
Longeveron® Announces U.S. FDA Grants Fast Track Designation for Lomecel-B™ for the Treatment of Mil...
GlobeNewswire
7/10/2024
Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Desig...
GlobeNewswire
7/9/2024
New Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 Conference
GlobeNewswire
7/8/2024
Truveta’s real-world data study comparing tirzepatide (Mounjaro) and semaglutide (Ozempic) for weigh...
GlobeNewswire
6/17/2024
Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Init...
GlobeNewswire
6/12/2024
Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspect...
GlobeNewswire
6/10/2024
Clinical ink Appoints Dr. Nicholas Alp, MD PhD FACC as Chief Medical Officer
